Europe — EMA
Herceptin (Trastuzumab)
Herceptin (trastuzumab) is an injectable ‑ intravenous infusion solution containing the monoclonal antibody trastuzumab, used in the European market.
Request sourcing
1
Pack/s
What is Trastuzumab?
Herceptin (trastuzumab) is an injectable ‑ intravenous infusion solution containing the monoclonal antibody trastuzumab, used in the European market. It targets the HER‑2 receptor and is prescribed for certain cancers, most commonly HER‑2‑positive breast and gastric tumours .
What is Trastuzumab used for?
Herceptin … ... ... … ... ... … ... ... ... ... ... ... ... ... ...
Product details
Drug
Trastuzumab
Route
Intravenous Use
Manufacturer
Roche Registration Gmbh
Origin
EU
Related products

Herceptin 440 mg
Trastuzumab · 440 MG
Herceptin
POWDER FOR SOLUTION
HOFFMANN-LA ROCHE LIMITED
CANADA

Perjeta-Herceptin 440 mg
Trastuzumab · 440 MG
Perjeta-Herceptin
KIT
HOFFMANN-LA ROCHE LIMITED
CANADA

Ogivri 150 mg
Trastuzumab · 150 MG
Ogivri
POWDER FOR SOLUTION
BIOSIMILAR COLLABORATIONS IRELAND LIMITED
IRELAND

Ogivri 440 mg
Trastuzumab · 440 MG
Ogivri
POWDER FOR SOLUTION
BIOSIMILAR COLLABORATIONS IRELAND LIMITED
IRELAND